{{Drugbox
| verifiedrevid = 443216648
| IUPAC_name = 1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-<br>2-(4-chlorophenoxy)ethanone
| image = Fipexide.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 34161-24-5
| ATC_prefix = N06
| ATC_suffix = BX05
| PubChem = 3351
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3234
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = TG44VME01D
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07345
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 254857

<!--Chemical data-->
| C=20 | H=21 | Cl=1 | N=2 | O=4 
| molecular_weight = 388.845 g/mol
| smiles = Clc4ccc(OCC(=O)N1CCN(CC1)Cc2ccc3OCOc3c2)cc4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H21ClN2O4/c21-16-2-4-17(5-3-16)25-13-20(24)23-9-7-22(8-10-23)12-15-1-6-18-19(11-15)27-14-26-18/h1-6,11H,7-10,12-14H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BFUJHVVEMMWLHC-UHFFFAOYSA-N
}}

'''Fipexide''' ('''Attentil''', '''Vigilor''') is a [[psychoactive drug]] of the [[piperazine]] [[chemical class]] which was developed in [[Italy]] in 1983.<ref>Missale C, Pasinetti G, Govoni S, Spano PF, Trabucchi M. Fipexide: a new drug for the regulation of dopaminergic system at the macromolecular level. Bollettino Chimico Farmaceutico. 1983 Feb;122(2):79-85.</ref> It was used as a [[nootropic]] drug in Italy and [[France]], mainly for the treatment of senile dementia,<ref>Bompani R, Scali G. Fipexide, an effective cognition activator in the elderly: a placebo-controlled, double-blind clinical trial. Current Medical Research and Opinion. 1986;10(2):99-106.</ref> but is no longer in common use due to the occurrence of rare adverse drug reactions including [[fever]]<ref>Guy C, Blay N, Rousset H, Fardeau V, Ollagnier M. Fever caused by fipexide. Evaluation of the national pharmacovigilance survey. Therapie. 1990 Sep-Oct;45(5):429-31.</ref> and [[hepatitis]]. Fipexide is similar in action to other nootropic drugs such as [[piracetam]]{{Citation needed|date=February 2017}} and bares a few similarities in chemical structure to [[centrophenoxine]]. Chemically, it is an amide union of [[parachlorophenoxyacetate]] and [[methylenedioxybenzylpiperazine]] (MDBZP), and has been shown to metabolize to the latter, which plays a significant role in its effects{{Citation needed|date=February 2017}}.

==See also==
* [[Substituted piperazine]]
* [[Befuraline]]
* [[Piberaline]]

==References==
{{Reflist|2}}

{{Nootropics}}
{{Piperazines}}

[[Category:Nootropics]]
[[Category:Benzodioxoles]]
[[Category:Piperazines]]
[[Category:Carboxamides]]
[[Category:Phenol ethers]]
[[Category:Chloroarenes]]
[[Category:Serotonin-norepinephrine-dopamine releasing agents]]


{{nervous-system-drug-stub}}